1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
640CB2C90B724FBEE6525806700425EE1
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-growing-biopharma-digital-marketing-impact-digitizing-launch-developing-talent?opendocument
18
19opendocument
2018.212.222.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Digital Marketing

Growing Biopharma Digital Marketing Impact: Digitizing Launch & Developing Talent

ID: 5438


Features:

6 Info Graphics

18 Data Graphics

300+ Metrics

3 Narratives


Pages/Slides: 34


Published: 2016


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Growing Biopharma Digital Marketing Impact: Digitizing Launch & Developing Talent”

STUDY OVERVIEW

Digital Marketing has transformed the speed with which patients, physicians, payers and other customer groups can be engaged during a new product launch. This instant access can rapidly enhance a launch trajectory and enable biopharmaceutical companies to more quickly maximize the value of new products.

Consequently, organizations are increasingly incorporating digital tactics into their pre-launch activities to support commercial, medical and clinical programs. Likewise, digital marketing teams are working more closely with brand teams to support and inform new product launches.

Best Practices, LLC undertook this study to provide insights into how savvy biopharma digital marketers are enhancing the medical and commercial potential of new products, through both pre-launch and launch support activities. The study also looks at what skills and traits are important for the digital marketing role.


KEY TOPICS

I. Digitizing Launch:

  • Top Commercial Support Activities
  • Top Clinical & Medical Support Areas
  • Aligning with NPP & Launch Teams

II. Talent Development:
  • Key Traits for New Hires
  • Developing & Aligning Talent


KEY METRICS
  • Impact of Digital Support on Pre-Launch Commercial Programs for New Products
  • Impact of Digital Support on Clinical and Medical Focused Pre-Launch Product Development Programs
  • Effective Activities for Improving Alignment between Digital Marketing Team and the Launch and Brand Teams
  • Important Skills and Characteristics for Hiring New Digital Marketers
  • Effective Tactics for Developing Digital Talent
  • Deployment Structure of Digital Talent and Expertise at Participating Companies

SAMPLE KEY FINDINGS
  • Interpersonal skills more important for new digital marketers than tech, healthcare or digital innovation background: “Interpersonal skills” were deemed most important for hiring new digital marketers (per 69% of companies), followed by “analytics skills” (62%). Both of these traits are critical for allowing new talent to build relationships, identify opportunities and articulate a digital path for healthcare organizations. “Healthcare experience” was seen as slightly more valuable than “innovative digital experience outside of healthcare.”


METHODOLOGY

Best Practices, LLC engaged 31 digital marketing leaders at 24 leading healthcare companies through a benchmarking survey instrument. Nearly 70% of participants serve at the level of director or above.


Industries Profiled:
Biopharmaceutical; Pharmaceutical; Medical Device; Manufacturing; Biotech; Consumer Products; Diagnostic; Health Care; Chemical; Consulting; Media


Companies Profiled:
Alkermes; Astellas; Baxter International; Bayer; CSL Behring; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline ; Insyght; Integra LifeSciences; Medi-Media; Merck; Mylan; Nektar Therapeutics; Novartis; Pfizer; Precision For Value; Prometheus Therapeutics & Diagnostics; Roche; Shionogi Inc.; Sunovion; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.